Patents by Inventor Brandon Dekosky

Brandon Dekosky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230221313
    Abstract: Disclosed herein are methods, compositions, systems, and kits related to functional testing of soluble polypeptides in a single-cell format.
    Type: Application
    Filed: November 11, 2022
    Publication date: July 13, 2023
    Inventors: Brandon DeKosky, Matias F. Gutierrez, Chengyu Chung, Ahmed Fahad, Nicoleen Boyle, Shuyan Jin
  • Publication number: 20220306735
    Abstract: The present disclosure relates generally to antibodies and Fc fusion proteins comprising Fc variants, and uses thereof. The Fc variants disclosed herein exhibit elevated affinity towards FcRn at pH 6.0, and/or rapidly disassociate from FcRn at pH 7.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 29, 2022
    Inventors: Brandon DEKOSKY, Peter D. KWONG, Wei JIN, Young Do KWON, Baoshan ZHANG
  • Publication number: 20220089694
    Abstract: Human monoclonal antibodies that specifically bind Ebola virus glycoprotein with nanomolar affinity are described. The monoclonal antibodies were isolated by bulk sorting of plasmablasts from a human Ebola virus vaccinee and pairing of the immunoglobulin heavy and light chain genes using emulsion PCR. The paired immunoglobulin genes were expressed using Fab yeast display to screen and characterize the antibodies. The Ebola virus-specific monoclonal antibodies can be used, for example, to diagnose and treat Ebola virus infection or Ebola virus disease in a subject.
    Type: Application
    Filed: December 19, 2019
    Publication date: March 24, 2022
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Nancy J. Sullivan, John Misasi, Brandon Dekosky, Kendra Elizabeth Leigh
  • Publication number: 20210000873
    Abstract: The present technology relates generally to compositions and methods for creating recombinant T cell receptor (TCR) libraries and methods of their therapeutic use. The compositions and methods of the present technology are useful for rapid isolation of antigen-specific TCR repertoires as personalized, targeted therapies for cancer and viral infection.
    Type: Application
    Filed: February 27, 2019
    Publication date: January 7, 2021
    Applicant: University of Kansas
    Inventors: Brandon DEKOSKY, Cheng-Yu CHUNG
  • Publication number: 20180044726
    Abstract: The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co-expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.
    Type: Application
    Filed: June 27, 2017
    Publication date: February 15, 2018
    Inventors: Scott HUNICKE-SMITH, Brandon DEKOSKY, Andy ELLINGTON, George GEORGIOU
  • Patent number: 9708654
    Abstract: The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: July 18, 2017
    Assignee: Board of Regents, The University of Texas System
    Inventors: Scott Hunicke-Smith, Brandon Dekosky, Andy Ellington, George Georgiou
  • Publication number: 20150141261
    Abstract: The present disclosure generally relates to sequencing two or more genes expressed in a single cell in a high-throughput manner. More particularly, the present disclosure relates to a method for high-throughput sequencing of pairs of transcripts co expressed in single cells (e.g., antibody VH and VL coding sequence) to determine pairs of polypeptide chains that comprise immune receptors.
    Type: Application
    Filed: June 17, 2013
    Publication date: May 21, 2015
    Inventors: Scott Hunicke-Smith, Brandon Dekosky, Andy Ellington, George Georgiou